Share this


Diabetes is a common life-long health condition. One in 20 people in Scotland have diabetes - the majority (88.2%) have type 2 diabetes and nearly 11% have type 1 diabetes (Scottish Government, 2014). It is thought that a further 49,000 people have undiagnosed type 2 diabetes (ScotPHO) and Diabetes UK estimates that at least 620,000 people in Scotland are at high risk of developing type 2 diabetes.  

To improve our understanding of the impact of changing diabetes care on our population, the complications associated with diabetes and the development of new therapies, NRS Diabetes, led by Professor Rory McCrimmon, supports the setup and delivery of clinical and epidemiological research across Scotland.

A wide range of studies is conducted in the NHS focusing on methods of treatment, diagnosis, care and prevention of diabetes and diabetes-related complications. This work also helps support our understanding of the causes of diabetes. Recent studies have included: 

  • internationally funded trials in type 1 diabetes (Bioresource)
  • a range of commercial trials of novel therapies for people with diabetes
  • a groundbreaking multicentre trial of insulin pump therapy (REPOSE)
  • novel trials of pharmacogenomics (DIRECT)
  • rates of amputation in people with diabetes